Institutional investors purchased a net $2.8 million shares of ATRS during the quarter ended March 2018. This may signal that the smart money is gaining interest in this company as the 37.46% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 5.0 Million shares of Antares Pharma Inc
RUSSELL INVESTMENT MANAGEMENT LL... Bought 890.5 Thousand shares of Antares Pharma Inc
GREAT POINT PARTNERS LLC Bought 500.0 Thousand shares of Antares Pharma Inc